{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:03:50Z","timestamp":1784696630824,"version":"3.55.0"},"reference-count":158,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T00:00:00Z","timestamp":1784419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Invasive candidiasis, predominantly driven by multidrug-resistant Candida species and intractable biofilms, represents an escalating global health crisis with mortality rates rivaling major infectious diseases. The clinical efficacy of conventional antifungal agents\u2014azoles, polyenes, and echinocandins\u2014is severely compromised by poor tissue penetration, dose-limiting systemic toxicity, and the rapid evolution of complex resistance mechanisms. Here, we review the two-decade structural evolution of nanotechnological interventions designed to overcome these pharmacological and biological barriers. We systematically analyze advanced nanosystems, including lipid-based formulations, natural polymers, and biogenic metallic nanostructures, highlighting their capacity to penetrate the dense extracellular polymeric substance (EPS), combat potential fungal \u2018nano-resistance\u2019, and significantly reduce metabolically dormant persister cell populations. The literature search was performed using the electronic databases PubMed, Scopus, Web of Science, and Google Scholar. Publications indexed between 2015 and 2025 were primarily considered, while seminal studies published before 2015 were included when necessary to provide historical context and foundational knowledge. We place specific emphasis on next-generation biomimetic and exosome-inspired nanocarriers, which significantly reduce systemic host toxicity while maximizing targeted antifungal efficacy. In this context, the synergistic integration of smart nanocarriers to actively disassemble fungal resistance networks, such as the target of rapamycin (TOR) signaling pathway and sphingolipid biosynthesis. Finally, we outline a strategic roadmap to bridge the translational \u201cValley of Death\u201d. By prioritizing manufacturing standardization, comprehensive long-term biosecurity profiling, and rationally designed biomimetic platforms, we propose an alternative way to outpace the evolutionary adaptations of fungal pathogenesis and translate these innovations into the clinic.<\/jats:p>","DOI":"10.3390\/jof12070530","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T07:54:13Z","timestamp":1784534053000},"page":"530","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bridging the \u201cValley of Death\u201d in Antifungal Therapy: Next-Generation Biomimetic and Exosome-Inspired Nanocarriers for Invasive Candidiasis"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6752-9246","authenticated-orcid":false,"given":"Bekir Mustafa","family":"Yo\u011furt\u00e7u","sequence":"first","affiliation":[{"name":"Department of Molecular Biology and Genetics, Graduate School of Science & Engineering, Yildiz Technical University, Istanbul 34220, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5250-3633","authenticated-orcid":false,"given":"Ilknur","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, \u0130stanbul Atlas University, Istanbul 34408, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12281-023-00455-3","article-title":"Candidiasis and Other Emerging Yeasts","volume":"17","author":"Sharma","year":"2023","journal-title":"Curr. Fungal Infect. Rep."},{"key":"ref_2","unstructured":"Jenks, J.D., and Tobin, E.H. (2026). Candidiasis. StatPearls, StatPearls Publishing."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Bongomin, F., Gago, S., Oladele, R.O., and Denning, D.W. (2017). Global and Multi-National Prevalence of Fungal Diseases\u2014Estimate Precision. J. Fungi, 3.","DOI":"10.3390\/jof3040057"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Li, X., Sholeh, M., Moghadam, M.A., Ostadrahimi, M., and Hosseini, S.S. (2026). Global Prevalence and Trends of Fluconazole Resistance in Non-Albicans Candida Species: A Systematic Review and Meta-Analysis. BMC Infect. Dis., 26.","DOI":"10.1186\/s12879-026-12653-8"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Tsiakalos, A., Papageorgiou, D., Pitiriga, V.C., Vogiatzi, C., Ziakas, P.D., Routsias, I., Dimitroulia, E., and Akinosoglou, K. (2026). Evolving Epidemiology and Emerging Antifungal Resistance in Vulvovaginal Candidosis: Evidence from a Five-Year Survey. Pathogens, 15.","DOI":"10.3390\/pathogens15050538"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1016\/j.apsb.2025.06.013","article-title":"Next-Generation Antifungal Drugs: Mechanisms, Efficacy, and Clinical Prospects","volume":"15","author":"Lu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Khan, M.I., Choudhry, H., Jahan, S., and Rather, I.A. (2023). Reversal of Azole Resistance in Candida albicans by Human Neutrophil Peptide. Biomedicines, 11.","DOI":"10.3390\/biomedicines11020513"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1080\/14756366.2022.2050224","article-title":"Echinocandins\u2014Structure, Mechanism of Action and Use in Antifungal Therapy","volume":"37","author":"Chmielewska","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_9","first-page":"20499361231161387","article-title":"Flucytosine and Its Clinical Usage","volume":"10","author":"Sigera","year":"2023","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Scalia, A.C., and Najmi, Z. (2025). Targeting Bacterial Biofilms on Medical Implants: Current and Emerging Approaches. Antibiotics, 14.","DOI":"10.3390\/antibiotics14080802"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Pierce, C.G., Vila, T., Romo, J.A., Montelongo-Jauregui, D., Wall, G., Ramasubramanian, A., and Lopez-Ribot, J.L. (2017). The Candida albicans Biofilm Matrix: Composition, Structure and Function. J. Fungi, 3.","DOI":"10.3390\/jof3010014"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e19199","DOI":"10.7717\/peerj.19199","article-title":"Nanoparticle-Based Antifungal Therapies Innovations Mechanisms and Future Prospects","volume":"13","author":"Wu","year":"2025","journal-title":"PeerJ"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Faustino, C., and Pinheiro, L. (2020). Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12010029"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jddst.2018.10.003","article-title":"Nanostructured Lipid Carriers Containing Amphotericin B: Development, In Vitro Release Assay, and Storage Stability","volume":"48","author":"Santiago","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/17435390.2024.2340467","article-title":"Advances in Nanotechnology for Improving the Targeted Delivery and Activity of Amphotericin B (2011\u20132023): A Systematic Review","volume":"18","author":"Mosaffa","year":"2024","journal-title":"Nanotoxicology"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Squitieri, D., Rizzo, S., Torelli, R., Mariotti, M., Sanguinetti, M., Cacaci, M., and Bugli, F. (2025). Studying Candida Biofilms Across Species: Experimental Models, Structural Diversity, and Clinical Implications. Pharmaceuticals, 19.","DOI":"10.3390\/ph19010008"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Jayathilaka, E.H.T.T., Nikapitiya, C., De Zoysa, M., and Whang, I. (2022). Antimicrobial Peptide Octominin-Encapsulated Chitosan Nanoparticles Enhanced Antifungal and Antibacterial Activities. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415882"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Romero-Montero, A., Melgoza-Ram\u00edrez, L.J., Ru\u00edz-Aguirre, J.A., Ch\u00e1vez-Santoscoy, A., Maga\u00f1a, J.J., Cort\u00e9s, H., Leyva-G\u00f3mez, G., and Prado-Audelo, M.L.D. (2023). Essential-Oils-Loaded Biopolymeric Nanoparticles as Strategies for Microbial and Biofilm Control: A Current Status. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25010082"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Dyck, K.V., Pinto, R.M., Pully, D., and Dijck, P.V. (2021). Microbial Interkingdom Biofilms and the Quest for Novel Therapeutic Strategies. Microorganisms, 9.","DOI":"10.3390\/microorganisms9020412"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6843","DOI":"10.2147\/IDR.S431745","article-title":"Contribution of N-Linked Mannosylation Pathway to Candida parapsilosis and Candida tropicalis Biofilm Formation","volume":"16","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Nett, J.E., and Andes, D.R. (2020). Contributions of the Biofilm Matrix to Candida Pathogenesis. J. Fungi, 6.","DOI":"10.3390\/jof6010021"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"An, L., Huang, X., Zhong, M., Wu, J., Liu, M., Geng, L., Li, Y., Wang, X., Yang, L., and Tan, J. (2025). In Vitro and In Vivo Antifungal Activity of Minocycline Albumin Nanoparticles in Combination with Fluconazole against Azole-Resistant Candida spp. BMC Microbiol., 25.","DOI":"10.1186\/s12866-025-04230-x"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ahamad, I., Bano, F., Anwer, R., Srivastava, P., Kumar, R., and Fatma, T. (2022). Antibiofilm Activities of Biogenic Silver Nanoparticles Against Candida albicans. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.741493"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1007\/s13346-024-01749-w","article-title":"Nanoparticles in the Battle against Candida auris Biofilms: Current Advances and Future Prospects","volume":"15","author":"Fayed","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"8350","DOI":"10.1021\/acsomega.1c05822","article-title":"Plausible Mechanistic Insights in Biofilm Eradication Potential against Candida spp. Using In Situ-Synthesized Tyrosol-Functionalized Chitosan Gold Nanoparticles as a Versatile Antifouling Coating on Implant Surfaces","volume":"7","author":"Yadav","year":"2022","journal-title":"ACS Omega"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.colsurfb.2016.03.013","article-title":"Time to Overcome Fluconazole Resistant Candida Isolates: Solid Lipid Nanoparticles as a Novel Antifungal Drug Delivery System","volume":"142","author":"Moazeni","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Baldim, I., Paziani, M.H., Grizante Bari\u00e3o, P.H., Kress, M.R.v.Z., and Oliveira, W.P. (2022). Nanostructured Lipid Carriers Loaded with Lippia sidoides Essential Oil as a Strategy to Combat the Multidrug-Resistant Candida auris. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14010180"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3109\/13693780802549594","article-title":"Biofilms of Non-Candida albicans Candida Species: Quantification, Structure and Matrix Composition","volume":"47","author":"Silva","year":"2009","journal-title":"Med. Mycol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e03185-24","DOI":"10.1128\/spectrum.03185-24","article-title":"Synergistic Antifungal Activity of Minocycline as an Effective Augmenting Agent of Fluconazole against Drug-Resistant Candida tropicalis","volume":"13","author":"Zhu","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Slavin, Y.N., and Bach, H. (2022). Mechanisms of Antifungal Properties of Metal Nanoparticles. Nanomaterials, 12.","DOI":"10.3390\/nano12244470"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.riam.2009.06.003","article-title":"Amphotericin B: Side effects and toxicity","volume":"26","year":"2009","journal-title":"Rev. Iberoam. Micol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.ijbiomac.2022.09.244","article-title":"Magnetic Chitosan Nanoparticles Loaded with Amphotericin B: Synthesis, Properties and Potentiation of Antifungal Activity against Common Human Pathogenic Fungal Strains","volume":"222","author":"Zareshahrabadi","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Du, W., Wang, Q., and Zhao, M. (2025). Innovative Antifungal Strategies to Combat Drug-Resistant Candida auris: Recent Advances and Clinical Implications. Front. Cell. Infect. Microbiol., 15.","DOI":"10.3389\/fcimb.2025.1641373"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Sutar, Y., Nabeela, S., Singh, S., Alqarihi, A., Solis, N., Ghebremariam, T., Filler, S., Ibrahim, A.S., Date, A., and Uppuluri, P. (2022). Niclosamide-Loaded Nanoparticles Disrupt Candida Biofilms and Protect Mice from Mucosal Candidiasis. PLoS Biol., 20.","DOI":"10.1371\/journal.pbio.3001762"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/s41598-020-58203-3","article-title":"Improved Efficacy of Antifungal Drugs in Combination with Monoterpene Phenols against Candida auris","volume":"10","author":"Shaban","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12247-026-10405-4","article-title":"Advanced Strategic Nanocarriers Containing Posaconazole as an Antifungal Drug for the Treatment of Fungal Infection, Targeting Topical, Ocular, Vaginal, and Systemic Delivery","volume":"21","author":"Shady","year":"2026","journal-title":"J. Pharm. Innov."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e04663","DOI":"10.1016\/j.heliyon.2020.e04663","article-title":"Recent Advances in Topical Carriers of Anti-Fungal Agents","volume":"6","author":"Garg","year":"2020","journal-title":"Heliyon"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/17460913.2026.2656109","article-title":"Mutation, Biofilm Formation, and Cell Wall Remodeling Contribute to Echinocandin Resistance of Candidozyma Auris","volume":"21","author":"Yang","year":"2026","journal-title":"Future Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.freeradbiomed.2016.09.014","article-title":"Endoplasmic Reticulum-Derived Reactive Oxygen Species (ROS) Is Involved in Toxicity of Cell Wall Stress to Candida albicans","volume":"99","author":"Yu","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"14382","DOI":"10.1038\/s41598-024-63149-x","article-title":"Synergistic and Potential Antifungal Properties of Tailored, One Pot Multicomponent Monoterpenes Co-Delivered with Fluconazole Encapsulated Nanostructure Lipid Carrier","volume":"14","author":"Radwan","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"107719","DOI":"10.1016\/j.micpath.2025.107719","article-title":"Designing of Eucalyptol Nanoemulsion Drug Delivery System Loaded with Amphotericin B for Candida albicans Biofilm Control: In Vitro and In Vivo Assessment Using the Galleria mellonella Model","volume":"205","author":"Keymaram","year":"2025","journal-title":"Microb. Pathog."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Rozhin, A., Batasheva, S., Kruychkova, M., Cherednichenko, Y., Rozhina, E., and Fakhrullin, R. (2021). Biogenic Silver Nanoparticles: Synthesis and Application as Antibacterial and Antifungal Agents. Micromachines, 12.","DOI":"10.3390\/mi12121480"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"104987","DOI":"10.1016\/j.chemphyslip.2020.104987","article-title":"Antifungal Activity of Farnesol Incorporated in Liposomes and Associated with Fluconazole","volume":"233","author":"Bezerra","year":"2020","journal-title":"Chem. Phys. Lipids"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Viegas, C., Patr\u00edcio, A.B., Prata, J.M., Nadhman, A., Chintamaneni, P.K., and Fonte, P. (2023). Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15061593"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12929-025-01161-7","article-title":"Chitosan-Based Formulations for Therapeutic Applications. A Recent Overview","volume":"32","author":"Gonciarz","year":"2025","journal-title":"J. Biomed. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1208\/s12249-014-0177-9","article-title":"Nanomedicine Scale-up Technologies: Feasibilities and Challenges","volume":"15","author":"Paliwal","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Spirescu, V.A., Chircov, C., Grumezescu, A.M., Vasile, B.\u0218., and Andronescu, E. (2021). Inorganic Nanoparticles and Composite Films for Antimicrobial Therapies. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094595"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Ge, X., Cao, Z., and Chu, L. (2022). The Antioxidant Effect of the Metal and Metal-Oxide Nanoparticles. Antioxidants, 11.","DOI":"10.3390\/antiox11040791"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"9173","DOI":"10.1039\/D4TB01484G","article-title":"Nanomaterial-Based Therapeutics for Enhanced Antifungal Therapy","volume":"12","author":"Liu","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/wnan.1389","article-title":"pH-Sensitive Stimulus-Responsive Nanocarriers for Targeted Delivery of Therapeutic Agents","volume":"8","author":"Karimi","year":"2016","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Wong, K.H., Lu, A., Chen, X., and Yang, Z. (2020). Natural Ingredient-Based Polymeric Nanoparticles for Cancer Treatment. Molecules, 25.","DOI":"10.3390\/molecules25163620"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Malik, N.U.A., Khalid, A.R., Gul, A., Munir, F., Haider, G., and Bhatti, M.F. (2024). CRISPR-Cas9-Mediated Genome Editing in Fungi: Current Scenario and Future Implications in Agriculture, Health, and Industry. Targeted Genome Engineering via CRISPR\/Cas9 in Plants, Academic Press.","DOI":"10.1016\/B978-0-443-26614-0.00022-9"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2147\/IDR.S164262","article-title":"Efficiency of Gold Nanoparticles Coated with the Antimicrobial Peptide Indolicidin against Biofilm Formation and Development of Candida spp. Clinical Isolates","volume":"11","author":"Maselli","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Uthayakumar, D., Sharma, J., Wensing, L., and Shapiro, R.S. (2021). CRISPR-Based Genetic Manipulation of Candida Species: Historical Perspectives and Current Approaches. Front. Genome Ed., 2.","DOI":"10.3389\/fgeed.2020.606281"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12951-021-01233-4","article-title":"CRISPR\/Cas9 Delivery by NIR-Responsive Biomimetic Nanoparticles for Targeted HBV Therapy","volume":"20","author":"Wang","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"8445","DOI":"10.1080\/07391102.2022.2134927","article-title":"Rapamycin and Torin2 Inhibit Candida auris TOR: Insights through Growth Profiling, Docking, and MD Simulations","volume":"41","author":"Biswas","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/2211068214561025","article-title":"TEER Measurement Techniques for in Vitro Barrier Model Systems","volume":"20","author":"Srinivasan","year":"2015","journal-title":"J. Lab. Autom."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.1038\/s41467-024-52411-5","article-title":"De Novo Engineering of Programmable and Multi-Functional Biomolecular Condensates for Controlled Biosynthesis","volume":"15","author":"Yu","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Guo, Y., Mao, Z., Ran, F., Sun, J., Zhang, J., Chai, G., and Wang, J. (2023). Nanotechnology-Based Drug Delivery Systems to Control Bacterial-Biofilm-Associated Lung Infections. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15112582"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.1128\/microbiolspec.MB-0008-2014","article-title":"Fungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm Drugs","volume":"3","author":"Nett","year":"2015","journal-title":"Microbiol. Spectr."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Xie, Y., Ke, W., Wong, K.H., and Wang, L. (2025). Persister Cells in Human Fungal Pathogens. PLoS Pathog., 21.","DOI":"10.1371\/journal.ppat.1013483"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Lin, Y.-K., Yang, S.-C., Hsu, C.-Y., Sung, J.-T., and Fang, J.-Y. (2021). The Antibiofilm Nanosystems for Improved Infection Inhibition of Microbes in Skin. Molecules, 26.","DOI":"10.3390\/molecules26216392"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.riam.2025.04.003","article-title":"Comparative Analysis of the Nephrotoxicity of Liposomal Amphotericin B and Amphotericin B Lipid Complex in Hematological Cancer Patients: A Multicenter Retrospective Study","volume":"42","author":"Edinger","year":"2025","journal-title":"Rev. Iberoam. Micol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Zhou, Z.-X., Yin, X.-D., Zhang, Y., Shao, Q.-H., Mao, X.-Y., Hu, W.-J., Shen, Y.-L., Zhao, B., and Li, Z.-L. (2022). Antifungal Drugs and Drug-Induced Liver Injury: A Real-World Study Leveraging the FDA Adverse Event Reporting System Database. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.891336"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1128\/AAC.39.9.1954","article-title":"Amphotericin B Liposomes with Prolonged Circulation in Blood: In Vitro Antifungal Activity, Toxicity, and Efficacy in Systemic Candidiasis in Leukopenic Mice","volume":"39","author":"Stearne","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_66","unstructured":"(2026, June 27). Pharmacodynamics and Pharmacokinetics Test\u2014CD Bioparticles. Available online: https:\/\/www.cd-bioparticles.net\/pharmacodynamics-and-pharmacokinetics-test."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Lambert, D., Lemaire, C., Camaioni, L., Billamboz, M., and Jawhara, S. (2026). Nature-Derived Ferulic Acid Hybrids with Enhanced Antifungal and Antivirulence Activity Against Candida albicans. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27062859"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/14728222.2017.1265105","article-title":"Efflux as a Mechanism of Antimicrobial Drug Resistance in Clinical Relevant Microorganisms: The Role of Efflux Inhibitors","volume":"21","author":"Willers","year":"2017","journal-title":"Expert. Opin. Ther. Targets"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"22355","DOI":"10.1038\/s41598-025-07037-y","article-title":"Simplified Kinetic Modeling for Predicting the Stability of Complex Biotherapeutics","volume":"15","author":"Zidar","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Basso, V., Tran, D.Q., Ouellette, A.J., and Selsted, M.E. (2020). Host Defense Peptides as Templates for Antifungal Drug Development. J. Fungi, 6.","DOI":"10.3390\/jof6040241"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Shandila, P., Mahatmanto, T., and Hsu, J.-L. (2025). Metal-Based Nanoparticles as Nanopesticides: Opportunities and Challenges for Sustainable Crop Protection. Processes, 13.","DOI":"10.3390\/pr13051278"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Khalifa, H.O., Oreiby, A., Abdelhamid, M.A.A., Ki, M.-R., and Pack, S.P. (2024). Biomimetic Antifungal Materials: Countering the Challenge of Multidrug-Resistant Fungi. Biomimetics, 9.","DOI":"10.3390\/biomimetics9070425"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12951-024-02415-6","article-title":"Synergistic Activity of Gold Nanoparticles with Amphotericin B on Persister Cells of Candida tropicalis Biofilms","volume":"22","author":"Dasilva","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"115093","DOI":"10.1016\/j.inoche.2025.115093","article-title":"In Vitro and In Vivo Synergistic Antifungal Effects of Microbially Synthesized Silver and Magnetic Iron Oxide Nanoparticles against Candida albicans","volume":"180","author":"Bahmaee","year":"2025","journal-title":"Inorg. Chem. Commun."},{"key":"ref_75","unstructured":"(2026, June 27). Targeted Nanoparticles Show Promise for More Effective Antifungal Treatments|Brown University. Available online: https:\/\/www.brown.edu\/news\/2025-05-12\/liposomes."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2217\/nnm-2018-0120","article-title":"Nanopharmaceuticals and Nanomedicines Currently on the Market: Challenges and Opportunities","volume":"14","author":"Farjadian","year":"2019","journal-title":"Nanomedicine"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"7722","DOI":"10.1038\/s41467-024-52107-w","article-title":"Cryo-EM Structures of Candida albicans Cdr1 Reveal Azole-Substrate Recognition and Inhibitor Blocking Mechanisms","volume":"15","author":"Peng","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Saffari Natanzi, A., Poudineh, M., Karimi, E., Khaledi, A., and Haddad Kashani, H. (2025). Innovative Approaches to Combat Antibiotic Resistance: Integrating CRISPR\/Cas9 and Nanoparticles against Biofilm-Driven Infections. BMC Med., 23.","DOI":"10.1186\/s12916-025-04323-4"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Li, Y., Sun, S., Li, G., Yang, Z., Xing, Y., Wang, R., Xuan, Y., and Yang, X. (2025). The TOR Signaling Pathway Governs Fungal Development, Virulence and Ustiloxin Biosynthesis in Ustilaginoidea virens. J. Fungi, 11.","DOI":"10.3390\/jof11040239"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Bahamondez-Canas, T.F., Heersema, L.A., and Smyth, H.D.C. (2019). Current Status of In Vitro Models and Assays for Susceptibility Testing for Wound Biofilm Infections. Biomedicines, 7.","DOI":"10.3390\/biomedicines7020034"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1021\/acs.biomac.9b00938","article-title":"Purely Polysaccharide-Based Biofilm Matrix Provides Size-Selective Diffusion Barriers for Nanoparticles and Bacteriophages","volume":"20","author":"Dunsing","year":"2019","journal-title":"Biomacromolecules"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Xiao, Y., Yang, Y., Sun, B., Yang, M., Lang, J., Dong, M., Chen, Z., Chen, S., and Wang, S. (2025). Nanomedicine in Fungal Keratitis: Current Applications and Future Prospects. Front. Microbiol., 16.","DOI":"10.3389\/fmicb.2025.1618046"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s13346-020-00740-5","article-title":"Challenges in Nanomedicine Clinical Translation","volume":"10","author":"Metselaar","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1016\/j.jmb.2015.09.002","article-title":"The Limitations of In Vitro Experimentation in Understanding Biofilms and Chronic Infection","volume":"427","author":"Roberts","year":"2015","journal-title":"J. Mol. Biol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/jam.15640","article-title":"Nanocarriers for Combating Biofilms: Advantages and Challenges","volume":"133","author":"Zhang","year":"2022","journal-title":"J. Appl. Microbiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte Membrane-Camouflaged Polymeric Nanoparticles as a Biomimetic Delivery Platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/03639045.2020.1871005","article-title":"Development and Machine-Learning Optimization of Mucoadhesive Nanostructured Lipid Carriers Loaded with Fluconazole for Treatment of Oral Candidiasis","volume":"47","author":"Elkomy","year":"2021","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"120990","DOI":"10.1016\/j.ijpharm.2021.120990","article-title":"A Transferosome-Loaded Bigel for Enhanced Transdermal Delivery and Antibacterial Activity of Vancomycin Hydrochloride","volume":"607","author":"Maji","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jsps.2023.05.011","article-title":"Solid Lipid Nanoparticles, an Effective Carrier for Classical Antifungal Drugs","volume":"31","author":"Almawash","year":"2023","journal-title":"Saudi Pharm. J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nrmicro.2017.99","article-title":"Targeting Microbial Biofilms: Current and Prospective Therapeutic Strategies","volume":"15","author":"Koo","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40265-013-0069-4","article-title":"Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity","volume":"73","author":"Hamill","year":"2013","journal-title":"Drugs"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.addr.2020.09.009","article-title":"Polymeric Micelles for the Delivery of Poorly Soluble Drugs: From Nanoformulation to Clinical Approval","volume":"156","author":"Hwang","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11095-020-02917-6","article-title":"Highlights in Mesoporous Silica Nanoparticles as a Multifunctional Controlled Drug Delivery Nanoplatform for Infectious Diseases Treatment","volume":"37","author":"Carvalho","year":"2020","journal-title":"Pharm. Res."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"de La Mata, F.J., Ortega, P., and Garc\u00eda-Gallego, S. (2022). Dendrimers and Dendritic Materials against Infectious Diseases. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14010154"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Nair, A., Mallya, R., Suvarna, V., Khan, T.A., Momin, M., and Omri, A. (2022). Nanoparticles\u2014Attractive Carriers of Antimicrobial Essential Oils. Antibiotics, 11.","DOI":"10.3390\/antibiotics11010108"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Estevez, M.B., Raffaelli, S., Mitchell, S.G., Faccio, R., and Albor\u00e9s, S. (2020). Biofilm Eradication Using Biogenic Silver Nanoparticles. Molecules, 25.","DOI":"10.3390\/molecules25092023"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2000537","DOI":"10.1002\/adfm.202000537","article-title":"Antifungal-Inbuilt Metal\u2013Organic-Frameworks Eradicate Candida albicans Biofilms","volume":"30","author":"Su","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1208\/s12249-023-02653-1","article-title":"Mucoadhesive, Fluconazole-Loaded Nanogels Complexed with Sulfhydryl-\u03b2-Cyclodextrin for Oral Thrush Treatment","volume":"24","author":"Khalid","year":"2023","journal-title":"AAPS PharmSciTech"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e1825","DOI":"10.1002\/wnan.1825","article-title":"Cell Membrane-Coated Nanoparticles for the Treatment of Bacterial Infection","volume":"14","author":"Ma","year":"2022","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s13346-021-01024-2","article-title":"Current Hurdles to the Translation of Nanomedicines from Bench to the Clinic","volume":"12","author":"Gonzalez","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.apsb.2025.01.014","article-title":"DELIVER: The Core Principles for the Clinic Translation of Nanomedicines","volume":"15","author":"Hu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.2147\/IJN.S128790","article-title":"Co-Delivery Nanoparticles with Characteristics of Intracellular Precision Release Drugs for Overcoming Multidrug Resistance","volume":"12","author":"Zhang","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"42633","DOI":"10.1038\/s41598-025-26841-0","article-title":"Chitosan Nanoparticles Loaded with Ribavirin, Carboplatin, and Thyme Oil Downregulate SNQ2, ERG11, CDR1, and MDR1 in Candida Strains","volume":"15","author":"Aghaei","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Fortunato, G.C., Marena, G.D., Silva, D.E.S., Ribeiro, T.R.M., Moreira, C.G., Nogueira, F.A.R., Di Filippo, L.D., Chorilli, M., Netto, A.V.d.G., and Bauab, T.M. (2025). A Silver (I) Complex-Loaded Lipid Nanoemulsion: A New Approach Against Candida albicans Biofilms. Drugs Drug Candidates, 4.","DOI":"10.3390\/ddc4040052"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.actbio.2025.09.003","article-title":"Macrophage Membrane-Camouflaged Dual Drug-Based Biomimetic pH-Responsive Nanomedicine for Synergistic Antifungal-Antioxidant Therapy in Oral Candidiasis","volume":"205","author":"Bao","year":"2025","journal-title":"Acta Biomater."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"du Pr\u00e9, S., Birch, M., Law, D., Beckmann, N., Sibley, G.E.M., Bromley, M.J., Read, N.D., and Oliver, J.D. (2020). The Dynamic Influence of Olorofim (F901318) on the Cell Morphology and Organization of Living Cells of Aspergillus fumigatus. J. Fungi, 6.","DOI":"10.3390\/jof6020047"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"84172","DOI":"10.1039\/C5RA10187E","article-title":"Impact of Storage Conditions and Storage Time on Silver Nanoparticles\u2019 Physicochemical Properties and Implications for Their Biological Effects","volume":"5","author":"Huk","year":"2015","journal-title":"RSC Adv."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"129075","DOI":"10.1016\/j.molliq.2025.129075","article-title":"Thermodynamic Insights into Nanoscale Stability: Temperature and Entropy in Action","volume":"442","author":"Hublikar","year":"2026","journal-title":"J. Mol. Liq."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Andreana, I., Bincoletto, V., Manzoli, M., Rod\u00e0, F., Giarraputo, V., Milla, P., Arpicco, S., and Stella, B. (2023). Freeze Drying of Polymer Nanoparticles and Liposomes Exploiting Different Saccharide-Based Approaches. Materials, 16.","DOI":"10.3390\/ma16031212"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/10717544.2017.1413444","article-title":"Fluconazole-Loaded Solid Lipid Nanoparticles Topical Gel for Treatment of Pityriasis Versicolor: Formulation and Clinical Study","volume":"25","author":"Salem","year":"2018","journal-title":"Drug Deliv."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Ali, E.M., and Abdallah, B.M. (2020). Effective Inhibition of Candidiasis Using an Eco-Friendly Leaf Extract of Calotropis-Gigantean-Mediated Silver Nanoparticles. Nanomaterials, 10.","DOI":"10.3390\/nano10030422"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Adam, R.Z., and Khan, S.B. (2021). Antimicrobial Efficacy of Silver Nanoparticles against Candida albicans: A Systematic Review Protocol. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0245811"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2301956","DOI":"10.1002\/adhm.202301956","article-title":"Feeding Next-Generation Nanomedicines to Europe: Regulatory and Quality Challenges","volume":"12","author":"Musazzi","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Danaei, M., Dehghankhold, M., Ataei, S., Davarani, F.H., Javanmard, R., Dokhani, A., Khorasani, S., and Mozafari, M.R. (2018). Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. Pharmaceutics, 10.","DOI":"10.3390\/pharmaceutics10020057"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s44222-023-00138-1","article-title":"Controlling the Biodistribution and Clearance of Nanomedicines","volume":"2","author":"Cabral","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1038\/s41598-024-52685-1","article-title":"A Careful Look at Lipid Nanoparticle Characterization: Analysis of Benchmark Formulations for Encapsulation of RNA Cargo Size Gradient","volume":"14","author":"Schober","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"100083","DOI":"10.1016\/j.ntm.2025.100083","article-title":"Nanoparticles for Drug Delivery: Insight into In Vitro and In Vivo Drug Release from Nanomedicines","volume":"4","author":"Ewii","year":"2025","journal-title":"Nano TransMed"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"13379","DOI":"10.1021\/acs.langmuir.1c02056","article-title":"Zeta Potential and Colloidal Stability Predictions for Inorganic Nanoparticle Dispersions: Effects of Experimental Conditions and Electrokinetic Models on the Interpretation of Results","volume":"37","author":"Pochapski","year":"2021","journal-title":"Langmuir"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Agbadamashi, D.J., and Price, C.L. (2025). Novel Strategies for Preventing Fungal Infections\u2014Outline. Pathogens, 14.","DOI":"10.3390\/pathogens14020126"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Rajput, A., Varshney, A., Bajaj, R., and Pokharkar, V. (2022). Exosomes as New Generation Vehicles for Drug Delivery: Biomedical Applications and Future Perspectives. Molecules, 27.","DOI":"10.3390\/molecules27217289"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"7953","DOI":"10.2147\/IJN.S525394","article-title":"MSC-Derived Extracellular Vesicles: Roles and Molecular Mechanisms for Tissue Repair","volume":"20","author":"Wu","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Yang, B., Wang, J., Jiang, H., Lin, H., Ou, Z., Ullah, A., Hua, Y., Chen, J., Lin, X., and Hu, X. (2021). Extracellular Vesicles Derived from Talaromyces marneffei Yeasts Mediate Inflammatory Response in Macrophage Cells by Bioactive Protein Components. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.603183"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s11671-026-04533-6","article-title":"Engineered Exosomes for Targeted Glioma Therapy: Overcoming the Blood-Brain Barrier with Nature-Inspired Nanocarriers","volume":"21","author":"Rahmani","year":"2026","journal-title":"Discov. Nano"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Lee, N.-H., You, S., Taghizadeh, A., Taghizadeh, M., and Kim, H.S. (2022). Cell Membrane-Cloaked Nanotherapeutics for Targeted Drug Delivery. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23042223"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Alehosseini, E., Shahiri Tabarestani, H., Kharazmi, M.S., and Jafari, S.M. (2022). Physicochemical, Thermal, and Morphological Properties of Chitosan Nanoparticles Produced by Ionic Gelation. Foods, 11.","DOI":"10.3390\/foods11233841"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Hashem, A.H., Shehabeldine, A.M., Ali, O.M., and Salem, S.S. (2022). Synthesis of Chitosan-Based Gold Nanoparticles: Antimicrobial and Wound-Healing Activities. Polymers, 14.","DOI":"10.3390\/polym14112293"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"102425","DOI":"10.1016\/j.mtbio.2025.102425","article-title":"Structure-Centered Design of Lipid-Based Nanocarriers to Overcome Biological Barriers","volume":"35","author":"Woo","year":"2025","journal-title":"Mater. Today Bio"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40121-020-00382-7","article-title":"Sixty Years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections","volume":"10","author":"Cavassin","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"e70210","DOI":"10.1002\/mbo3.70210","article-title":"Nanomedicine Strategies Against Biofilm-Associated Infections: Advances, Challenges, and Translational Barriers","volume":"15","author":"Farah","year":"2025","journal-title":"Microbiologyopen"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"10584","DOI":"10.1073\/pnas.1709210114","article-title":"Isolation of Exosomes from Whole Blood by Integrating Acoustics and Microfluidics","volume":"114","author":"Wu","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Li, Y., Liu, Y., Jiang, Y., Yang, Y., Ni, W., Zhang, W., and Tan, L. (2025). New Antifungal Strategies and Drug Development against WHO Critical Priority Fungal Pathogens. Front. Cell. Infect. Microbiol., 15.","DOI":"10.3389\/fcimb.2025.1662442"},{"key":"ref_132","first-page":"e16445","article-title":"Conventional Amphotericin B Associated Nephrotoxicity in Patients with Hematologic Malignancies","volume":"13","author":"Gursoy","year":"2021","journal-title":"Cureus"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2.26.1","DOI":"10.1002\/cptx.21","article-title":"Quantification of Lactate Dehydrogenase for Cell Viability Testing Using Cell Lines and Primary Cultured Astrocytes","volume":"72","author":"Kaja","year":"2017","journal-title":"Curr. Protoc. Toxicol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"14403","DOI":"10.1021\/es4033106","article-title":"Influence of Bovine Serum Albumin and Alginate on Silver Nanoparticle Dissolution and Toxicity to Nitrosomonas europaea","volume":"47","author":"Ostermeyer","year":"2013","journal-title":"Environ. Sci. Technol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"41605","DOI":"10.1021\/acsnano.5c13661","article-title":"Membrane-Targeting Poly(Amino Acids) with a Phage-Like Action Process for Antifungal Therapy","volume":"19","author":"Zhao","year":"2025","journal-title":"ACS Nano"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Deng, J.-H., Zhang, X.-G., Wang, G.-S., Luo, J.-N., Wang, J., Qi, X.-M., and Li, Y.-L. (2022). Effect of Cinnamaldehyde on C. Albicans Cell Wall and (1,3)-\u03b2-D-Glucans in Vivo. BMC Complement. Med. Ther., 22.","DOI":"10.1186\/s12906-021-03468-y"},{"key":"ref_137","first-page":"5136","article-title":"In Vitro Effects of Chitosan Nanoparticles on Proliferation of Human Gastric Carcinoma Cell Line MGC803 Cells","volume":"11","author":"Qi","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"8216","DOI":"10.3390\/ijms15058216","article-title":"Efficient pH Dependent Drug Delivery to Target Cancer Cells by Gold Nanoparticles Capped with Carboxymethyl Chitosan","volume":"15","author":"Madhusudhan","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e01755-18","DOI":"10.1128\/mBio.01755-18","article-title":"The Multifunctional Fungal Ergosterol","volume":"9","author":"Rodrigues","year":"2018","journal-title":"mBio"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Kazan, K., and Gardiner, D.M. (2017). Targeting Pathogen Sterols: Defence and Counterdefence?. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006297"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/microbiolspec.MB-0020-2015","article-title":"Candida Biofilms: Development, Architecture, and Resistance","volume":"3","author":"Chandra","year":"2015","journal-title":"Microbiol. Spectr."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Hetta, H.F., Ramadan, Y.N., Al-Kadmy, I.M.S., Ellah, N.H.A., Shbibe, L., and Battah, B. (2023). Nanotechnology-Based Strategies to Combat Multidrug-Resistant Candida auris Infections. Pathogens, 12.","DOI":"10.3390\/pathogens12081033"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"114083","DOI":"10.1016\/j.addr.2021.114083","article-title":"Clinical Translation of Nanomedicines: Challenges, Opportunities, and Keys","volume":"181","author":"Younis","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Akhter, M.H., Khalilullah, H., Gupta, M., Alfaleh, M.A., Alhakamy, N.A., Riadi, Y., and Md, S. (2021). Impact of Protein Corona on the Biological Identity of Nanomedicine: Understanding the Fate of Nanomaterials in the Biological Milieu. Biomedicines, 9.","DOI":"10.3390\/biomedicines9101496"},{"key":"ref_145","first-page":"e70093","article-title":"The Antifungal Activity of Chitosan Nanoparticle-Incorporated Probiotics Against Oral Candidiasis","volume":"16","author":"Pillai","year":"2024","journal-title":"Cureus"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"100420","DOI":"10.1016\/j.nxnano.2026.100420","article-title":"Nanoparticles in the Fight against Antimicrobial Challenges: A Comprehensive Review","volume":"9","author":"Pathak","year":"2026","journal-title":"Next Nanotechnol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41368-018-0013-2","article-title":"ERG3 and ERG11 Genes Are Critical for the Pathogenesis of Candida albicans during the Oral Mucosal Infection","volume":"10","author":"Zhou","year":"2018","journal-title":"Int. J. Oral. Sci."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"e70061","DOI":"10.1111\/apm.70061","article-title":"Biogenic Silver Nanoparticles Exhibit Antifungal and Antibiofilm Activity Against Candida albicans via Intracellular ROS Production","volume":"133","author":"Chandrakar","year":"2025","journal-title":"APMIS"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Patr\u00f3n-Romero, L., Luque-Morales, P.A., Loera-Casta\u00f1eda, V., Lares-Asseff, I., Leal-\u00c1vila, M.\u00c1., Alvelais-Palacios, J.A., Plasencia-L\u00f3pez, I., and Almanza-Reyes, H. (2022). Mitochondrial Dysfunction Induced by Zinc Oxide Nanoparticles. Crystals, 12.","DOI":"10.3390\/cryst12081089"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.fct.2013.04.031","article-title":"Fas Receptor-Deficient Lpr Mice Are Protected against Acetaminophen Hepatotoxicity Due to Higher Glutathione Synthesis and Enhanced Detoxification of Oxidant Stress","volume":"58","author":"Williams","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"ref_151","unstructured":"(2026, June 28). Early Development Considerations for Innovative Combination Products|FDA, Available online: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/early-development-considerations-innovative-combination-products."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Ridoy, M.N., and Supto, S.T.J. (2025). Environmental Impacts and Sustainability of Nanomaterials in Water and Soil Systems. Mater. Proc., 26.","DOI":"10.3390\/materproc2025026006"},{"key":"ref_153","unstructured":"Pralong, A., Jacquemart, R., and Cordovado, K. (Enable Biotech, 2025). Exosome Manufacturing: Overcoming Purification and Scalability Challenges on the Path to Clinical Readiness, Enable Biotech."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Wang, B., Lu, J., Zhang, X., Hu, R., and Ma, H. (2025). Advances in Nanomaterial-Mediated CRISPR\/Cas Delivery: From Lipid Nanoparticles to Vesicle-Derived Systems. Front. Bioeng. Biotechnol., 13.","DOI":"10.3389\/fbioe.2025.1669104"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Kamli, M.R., Alzahrani, E.A., Albukhari, S.M., Ahmad, A., Sabir, J.S.M., and Malik, M.A. (2022). Combination Effect of Novel Bimetallic Ag-Ni Nanoparticles with Fluconazole against Candida albicans. J. Fungi, 8.","DOI":"10.3390\/jof8070733"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1124\/dmd.121.000568","article-title":"The In Vivo Pharmacokinetics of Block Copolymers Containing Polyethylene Glycol Used in Nanocarrier Drug Delivery Systems","volume":"50","author":"Yin","year":"2022","journal-title":"Drug Metab. Dispos."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"45962","DOI":"10.1021\/acsomega.2c06211","article-title":"Nanomaterial-Based Antimicrobial Coating for Biomedical Implants: New Age Solution for Biofilm-Associated Infections","volume":"7","author":"Sahoo","year":"2022","journal-title":"ACS Omega"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Liu, Y.-C., Chen, S.-M., Zong, H., Hou, W.-T., Qiu, X.-R., Guo, S.-Y., Sun, Y.-F., Jiang, Y.-Y., and An, M.-M. (2021). Evaluation of the in Vitro Activity and in Vivo Efficacy of Anidulafungin-Loaded Human Serum Albumin Nanoparticles Against Candida albicans. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.788442"}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/12\/7\/530\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:29:35Z","timestamp":1784694575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/12\/7\/530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,19]]},"references-count":158,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["jof12070530"],"URL":"https:\/\/doi.org\/10.3390\/jof12070530","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,19]]}}}